⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1414053 | 1.00 | — | — | |
| SCHEMBL30899 | 1.00 | — | — | |
| SCHEMBL2869472 | 0.97 | TSHR (0.62) | — | |
| SCHEMBL1076957 | 0.97 | TSHR (0.62) | — | |
| SCHEMBL298912 | 0.97 | — | — | |
| SCHEMBL1395419 | 0.97 | TSHR (0.62) | — | |
| SCHEMBL169329 | 0.97 | TSHR (0.62) | — | |
| SCHEMBL1114864 | 0.97 | TSHR (0.62) | — | |
| SCHEMBL10980289 | 0.97 | TSHR (0.62) | — | |
| SCHEMBL3078400 | 0.97 | TSHR (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9301988-A | — | — | None | — | — | JP | disclosed |
| US-20180296674-A1 | LIQUID PHARMACEUTICAL COMPOSITION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2018-10-18 | — | — | US | disclosed |
| WO-2016124588-A1 | LIQUID PHARMACEUTICAL COMPOSITION | ARES TRADING S.A. (CH) | 2016-08-11 | — | — | WO | disclosed |
| EP-3053573-A1 | LIQUID PHARMACEUTICAL COMPOSITION | ARES TRADING S.A. (CH) | 2016-08-10 | — | — | EP | disclosed |
| EP-3053572-A1 | Liquid pharmaceutical composition | ARES TRADING S.A. (CH) | 2016-08-10 | — | — | EP | disclosed |
| WO-2012025760-A1 | PROCESS FOR THE BORYLATION OF ARENES AND HETEROARYLS | THE UNIVERSITY OF MANCHESTER (GB) | 2012-03-01 | — | — | WO | disclosed |
| JP-H09301988-A | GLUCOSAMINE DERIVATIVE | SUMITOMO PHARMACEUT CO LTD | 1997-11-25 | — | — | JP | disclosed |